Gastroenterology

digestive-health-products-key-factors-and-market-dynamics

Articles

Digestive Health Products: Exploring the Market Dynamics and Key Factors Driving the Demand

Over the years, the landscape of Digestive Health Products has undergone significant evolution driven by advancements in scientific understanding, changing consumer preferences, and emerging market trends. As per the latest study by DelveInsight, the global Digestive Health Products market was valued at USD 39,345.36 million in 2023, growing at a CAGR of 7.75% during the forecast period from 2024 to 2030 to reach USD 61,444.73 million by 2030. Initially, Digestive Health Products primarily consisted of basic remedies such as antacids and laxatives, targeting specific gastrointestinal symptoms. However, with growing awareness of the intricate relationship between gut h...

Explore More...

Pharma News for GSK, Roche, Eli Lilly, Coherus

Phase III RUBY Trial of Jemperli Plus Chemotherapy Updates; FDA Approves Roche’s Vabysmo for RVO; FDA Grants Priority Review to Tovorafenib Low-Grade Glioma; FDA Approves Lilly’s Omvoh; FDA Approves Toripalimab for Nasopharyngeal Carcinoma; FDA Fast Track Designation to ONCT-534 R/R mCRPC

MedTech News for Olympus, Abbott, Cardio Flow

Cardio Flow’s FreedomFlow Orbital Atherectomy Peripheral Platform; Medtronic’s Aurora EV- ICD System to Treat Arrhythmias; GE Healthcare and Novo Nordisk Announces Collaboration; Olympus’s EVIS X1 Endoscopy System; Medtronic’s Evolut TAVR Platform Outperformed Surgery with Sustained Valve Performance; Abbott’s Minimally Invasive Devices for People with Leaky Heart Valves

xphozah-for-chronic-kidney-disease-treatment

Ardelyx Overcomes Hurdles to Secure FDA Approval for Xphozah in Chronic Kidney Disease Treatment

etrasimod-for-ulcerative-colitis-treatment

New Player in Ulcerative Colitis Treatment: Pfizer’s Etrasimod Entry Counters BMS’ Zeposia

Pharma News for Amgen, Anaptys, Sanofi, Boehringer

Amgen to Acquire Horizon Therapeutics; Sanofi and Teva Announce Collaboration; Boehringer Obesity Drug Trial Update; FDA Places Partial Clinical Hold on IND for Lacutamab in CTCL/PTCL; Anaptys Announces Phase 3 Clinical Trial Results of Imsidolimab; Orphan Drug Designation to GC Biopharma’s GC1126A

Pharma News for Almirall, GSK, Cellectar

FDA Approves Ojjaara for Myelofibrosis; EMA Grants PRIME Designation to Iopofosine I-131; EBGLYSS Receives Positive CHMP Opinion; FDA Accepts Resmetirom NDA; FDA Fast Track Designation to KT-333 for PTCL; RedHill Announces FDA sNDA Approval for Talicia®

FDA Approves RINVOQ for Crohn’s Disease; FDA Approves Krystal Biotech’s Gene Therapy Vyjuvek; FDA Approves EPKINLY to Treat R/R DLBCL; FDA Orphan Drug Designation to Mitazalimab; Phase 3 Trial Result of OCS-01 Eye Drops; TAGRISSO® + Chemotherapy for the EGFR-mutated Advanced Lung Cancer

Probiotics Market Dynamics, Forecast , Key Companies and Evolving Trends

Probiotics: How Market Dynamics are Evolving with the Ongoing Development?

MedTech News and Updates for SOPHiA GENETICS, QIAGEN, Co-Diagnostics, Abbott, SpectraWAVE, Bioelectronic Medicine

Eko’s AI-powered Sensora Platform; SOPHiA GENETICS and QIAGEN Announced Partnership; Co-Diagnostics’s At-Home and Point-of-Care Co-Dx PCR Home™ Platform; Abbott’s Minimally Invasive Heart Devices Updates; SpectraWAVE’s HyperVue™ Intravascular Imaging System; FDA Approval to Bioelectronic Medicine’s Bioelectric Technology

Pharma News and Updates for Actinium, Apellis, Chiesi, IVERIC, Travere, Takeda

Actinium Announces Phase III SIERRA Trial Results; FDA Approves Apellis’s Geographic Atrophy Drug; FDA Gives Green Light to Chiesi’s Lamzede; FDA Accepts NDA and Grants Priority Review for Avacincaptad Pegol; FDA Approves Travere’s Kidney Disorder Drug; Takeda Presents Phase 3 GRAPHITE Study Results

ppar-and-nox-agonist-for-primary-biliary-cholangitis-treatment

PPAR and NOX Agonist: Savior of Underserved Primary Biliary Cholangitis Patients

eosinophilic-esophagitis-treatment-outlook

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Gastroenterology

Digestive Health Products: Exploring the Market Dynamics and Key Factors Driving the Demand

Phase III RUBY Trial of Jemperli Plus Chemotherapy Updates; FDA Approves Roche’s Vabysmo for RVO; FDA Grants Priority Review to Tovorafenib Low-Grade Glioma; FDA Approves Lilly’s Omvoh; FDA Approves Toripalimab for Nasopharyngeal Carcinoma; FDA Fast Track Designation to ONCT-534 R/R mCRPC

Ardelyx Overcomes Hurdles to Secure FDA Approval for Xphozah in Chronic Kidney Disease Treatment

New Player in Ulcerative Colitis Treatment: Pfizer’s Etrasimod Entry Counters BMS’ Zeposia

FDA Approves Ojjaara for Myelofibrosis; EMA Grants PRIME Designation to Iopofosine I-131; EBGLYSS Receives Positive CHMP Opinion; FDA Accepts Resmetirom NDA; FDA Fast Track Designation to KT-333 for PTCL; RedHill Announces FDA sNDA Approval for Talicia®

Revolutionizing Pain Management: The Growth in Innovative Devices and Rise of Market

Diagnostic Precision: The Rise of Medical Imaging Technologies and Market Trends

More Views & Analysis

What Is Herbal Medicine? A Comprehensive Exploration of Nature’s Healing Gift

A Beacon of Hope: A Look at the Latest Advances in Emerging Therapies for Liver Cirrhosis Treatment

FDA Approves RINVOQ for Crohn’s Disease; FDA Approves Krystal Biotech’s Gene Therapy Vyjuvek; FDA Approves EPKINLY to Treat R/R DLBCL; FDA Orphan Drug Designation to Mitazalimab; Phase 3 Trial Result of OCS-01 Eye Drops; TAGRISSO® + Chemotherapy for the EGFR-mutated Advanced Lung Cancer

Probiotics: How Market Dynamics are Evolving with the Ongoing Development?

PPAR and NOX Agonist: Savior of Underserved Primary Biliary Cholangitis Patients

Is it the Dawn of Biologics in the Eosinophilic Esophagitis Treatment Landscape?

Subscribe to our Updates

Daily

Weekly

Monthly